XBiotech Inc. (XBIT)

XBiotech Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Net Income	-30.74	-24.56	-32.9	-17.41	-11.22	668.63
Depreciation & Amortization	1.73	1.74	2.61	2.65	2.24	2.36
Share-Based Compensation	2.94	3.26	5.06	4.46	12.58	3.36
Other Operating Activities	4.95	0.83	10.4	79.75	-68.75	-692.62
Operating Cash Flow	-21.12	-18.73	-14.82	69.45	-65.15	-18.27
Capital Expenditures	-0.61	-0.36	-0.59	-3.53	-3.73	-0.2
Acquisitions	0	0	0	0	0	675
Change in Investments	61.86	61.86	-63.31	0	0	0
Investing Cash Flow	61.25	61.5	-63.89	-3.53	-3.73	674.8
Dividends Paid	0	0	0	-75	0	0
Share Issuance / Repurchase	0.06	-0.01	0	8	-409.72	42.1
Debt Issued / Paid	10	0	0	0	0	0
Financing Cash Flow	10.06	-0.01	0	-67.01	-409.72	42.1
Exchange Rate Effect	-1.62	-0.05	-0.96	0.71	1.37	0.15
Net Cash Flow	48.56	42.72	-79.68	-0.38	-477.23	698.77
Free Cash Flow	-21.73	-19.09	-15.41	65.92	-68.88	-18.47
Free Cash Flow Margin	-	-	-384.26%	358.38%	-156.55%	-
Free Cash Flow Per Share	-0.71	-0.63	-0.51	2.19	-2.23	-0.47

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).